|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Orditura M, Galizia G, Sforza V,
Gambardella V, Fabozzi A, Laterza MM, Andreozzi F, Ventriglia J,
Savastano B, Mabilia A, et al: Treatment of gastric cancer. World J
Gastroenterol. 20:1635–1649. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim C, Mulder K and Spratlin J: How
prognostic and predictive biomarkers are transforming our
understanding and management of advanced gastric cancer.
Oncologist. 19:1046–1055. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fabian MR, Sonenberg N and Filipowicz W:
Regulation of mRNA translation and stability by microRNAs. Annu Rev
Biochem. 79:351–379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guo H, Ingolia NT, Weissman JS and Bartel
DP: Mammalian microRNAs predominantly act to decrease target mRNA
levels. Nature. 466:835–840. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
McManus MT: MicroRNAs and cancer. Semin
Cancer Biol. 13:253–258. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Farazi TA, Spitzer JI, Morozov P and
Tuschl T: miRNAs in human cancer. J Pathol. 223:102–115. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shrestha S, Hsu SD, Huang WY, Huang HY,
Chen W, Weng SL and Huang HD: A systematic review of microRNA
expression profiling studies in human gastric cancer. Cancer Med.
3:878–888. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu X, Lv M, Wang H and Guan W:
Identification of circulating microRNAs as novel potential
biomarkers for gastric cancer detection: A systematic review and
meta-analysis. Dig Dis Sci. 59:911–919. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu Y, Zhang W, Liu K, Liu S, Ji B and
Wang Y: miR-138 suppresses cell proliferation and invasion by
inhibiting SOX9 in hepatocellular carcinoma. Am J Transl Res.
8:2159–2168. 2016.PubMed/NCBI
|
|
13
|
Zhao L, Yu H, Yi S, Peng X, Su P, Xiao Z,
Liu R, Tang A, Li X, Liu F, et al: The tumor suppressor miR-138-5p
targets PD-L1 in colorectal cancer. Oncotarget. 7:45370–45384.
2016.PubMed/NCBI
|
|
14
|
Zhu Z, Tang J, Wang J, Duan G, Zhou L and
Zhou X: MiR-138 acts as a tumor suppressor by targeting EZH2
and enhances cisplatin-induced apoptosis in osteosarcoma cells.
PLoS One. 11:e01500262016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wei J, Nduom EK, Kong LY, Hashimoto Y, Xu
S, Gabrusiewicz K, Ling X, Huang N, Qiao W, Zhou S, et al: MiR-138
exerts anti-glioma efficacy by targeting immune checkpoints. Neuro
Oncol. 18:639–648. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li J, Wang Q, Wen R, Liang J, Zhong X,
Yang W, Su D and Tang J: MiR-138 inhibits cell proliferation and
reverses epithelial-mesenchymal transition in non-small cell lung
cancer cells by targeting GIT1 and SEMA4C. J Cell Mol Med.
19:2793–2805. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu R, Zeng G, Gao J, Ren Y, Zhang Z, Zhang
Q, Zhao J, Tao H and Li D: miR-138 suppresses the proliferation of
oral squamous cell carcinoma cells by targeting Yes-associated
protein 1. Oncol Rep. 34:2171–2178. 2015.PubMed/NCBI
|
|
18
|
Li B, Yang XX, Wang D and Ji HK:
MicroRNA-138 inhibits proliferation of cervical cancer cells by
targeting c-Met. Eur Rev Med Pharmacol Sci. 20:1109–1114.
2016.PubMed/NCBI
|
|
19
|
Zhang J, Liu D, Feng Z, Mao J, Zhang C, Lu
Y, Li J, Zhang Q, Li Q and Li L: MicroRNA-138 modulates metastasis
and EMT in breast cancer cells by targeting vimentin. Biomed
Pharmacother. 77:135–141. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jin Y, Zhao M, Xie Q, Zhang H, Wang Q and
Ma Q: MicroRNA-338-3p functions as tumor suppressor in breast
cancer by targeting SOX4. Int J Oncol. 47:1594–1602.
2015.PubMed/NCBI
|
|
21
|
Schröder J, Ansaloni S, Schilling M, Liu
T, Radke J, Jaedicke M, Schjeide BM, Mashychev A, Tegeler C,
Radbruch H, et al: MicroRNA-138 is a potential regulator of memory
performance in humans. Front Hum Neurosci. 8:5012014.PubMed/NCBI
|
|
22
|
Xiao L, Zhou H, Li XP, Chen J, Fang C, Mao
CX, Cui JJ, Zhang W, Zhou HH, Yin JY, et al: MicroRNA-138 acts as a
tumor suppressor in non small cell lung cancer via targeting YAP1.
Oncotarget. 7:40038–40046. 2016.PubMed/NCBI
|
|
23
|
Yao Y, Suo AL, Li ZF, Liu LY, Tian T, Ni
L, Zhang WG, Nan KJ, Song TS and Huang C: MicroRNA profiling of
human gastric cancer. Mol Med Rep. 2:963–970. 2009.PubMed/NCBI
|
|
24
|
Chen J, Ju HL, Yuan XY, Wang TJ and Lai
BQ: SOX4 is a potential prognostic factor in human cancers: a
systematic review and meta-analysis. Clin Transl Oncol. 18:65–72.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Han R, Huang S, Bao Y, Liu X, Peng X, Chen
Z, Wang Q, Wang J, Zhang Q, Wang T, et al: Upregulation of SOX4
antagonizes cellular senescence in esophageal squamous cell
carcinoma. Oncol Lett. 12:1367–1372. 2016.PubMed/NCBI
|
|
26
|
Liu Y, Cui L, Huang J, Ji EH, Chen W,
Messadi D and Hu S: SOX4 promotes progression in OLP-associated
squamous cell carcinoma. J Cancer. 7:1534–1540. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vervoort SJ, van Boxtel R and Coffer PJ:
The role of SRY-related HMG box transcription factor 4 (SOX4) in
tumorigenesis and metastasis: Friend or foe? Oncogene.
32:3397–3409. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Parvani JG and Schiemann WP: Sox4, EMT
programs, and the metastatic progression of breast cancers:
Mastering the masters of EMT. Breast Cancer Res. 15:R722013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Vervoort SJ, Lourenço AR, van Boxtel R and
Coffer PJ: SOX4 mediates TGF-β-induced expression of mesenchymal
markers during mammary cell epithelial to mesenchymal transition.
PLoS One. 8:e532382013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tiwari N, Tiwari VK, Waldmeier L, Balwierz
PJ, Arnold P, Pachkov M, Meyer-Schaller N, Schübeler D, van
Nimwegen E and Christofori G: Sox4 is a master regulator of
epithelial-mesenchymal transition by controlling Ezh2 expression
and epigenetic reprogramming. Cancer Cell. 23:768–783. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ishiwata T: Cancer stem cells and
epithelial-mesenchymal transition: Novel therapeutic targets for
cancer. Pathol Int. 66:601–608. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yeh YM, Chuang CM, Chao KC and Wang LH:
MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis
by targeting SOX4 and HIF-1α. Int J Cancer. 133:867–878. 2013.
View Article : Google Scholar : PubMed/NCBI
|
